Full-Time

Senior/Scientist

RNA Assay Dev

Posted on 9/25/2024

Natera

Natera

1,001-5,000 employees

Genetic testing and diagnostics solutions provider

Biotechnology
Healthcare

Compensation Overview

$108.8k - $163.1kAnnually

Senior

San Bruno, CA, USA

On-site role working out of South San Francisco, CA office.

Category
Genomics
Biology Lab & Research
Biology & Biotech
Requirements
  • Doctorate in molecular biology, biochemistry, or closely related field with a minimum of 2 years experience in assay development for the life science industry.
  • Master’s degree in molecular biology, biochemistry, or closely related field with a minimum of 6 years experience in assay development for the life science industry.
  • Bachelor’s degree in molecular biology, biochemistry, or closely related field with a minimum of 8 years experience in assay development for the life science industry.
  • Proven track record of launching RNA-sequencing-based clinical assays or reagent kits (bulk RNA-seq, smRNA-seq, scRNA-seq, etc).
  • Demonstrated success with cross-functional collaborations.
  • Familiarity with laboratory automation and building assays with scale and automation in mind.
  • Must be capable of independently planning and executing complex studies, interpreting results, and making data-driven decisions.
  • Must have experience in optimizing laboratory processes, identifying risks, and troubleshooting issues.
  • Must have good organization and time management skills.
  • Must have experience performing statistical analyses in Excel or similar software. Coding proficiency is a plus.
  • Must be familiar with bioinformatics software commonly used in RNA-sequencing analysis (STAR, samtools, DESeq2, etc.).
  • Must have experience working in a regulated laboratory environment.
Responsibilities
  • Join a team to research, build, and validate high-throughput RNA-sequencing assays.
  • Explore the feasibility of emerging technologies in the RNA-sequencing field.
  • Independently design and execute complex studies, analyze and interpret data, and communicate findings to both scientists and broad audiences.
  • Collaborate with assay development scientists, automation engineers, and computational biologists to develop all aspects of a production-grade clinical assay, including extraction, library preparation, quality control, and analytical pipeline.

Natera focuses on genetic testing and diagnostics, providing advanced solutions for cancer patients, transplant patients, and individuals assessing hereditary health risks. Their main technology is cell-free DNA (cfDNA) testing, which analyzes DNA fragments in the blood to detect minimal traces of cancer and assess organ health. Natera differentiates itself by offering specialized tests like the Signatera ctDNA test and Panorama NIPT for prenatal screening, along with genetic counseling services. The company's goal is to enhance patient care through accurate testing and personalized guidance.

Company Stage

IPO

Total Funding

$149.9M

Headquarters

Austin, Texas

Founded

2004

Growth & Insights
Headcount

6 month growth

9%

1 year growth

25%

2 year growth

66%
Simplify Jobs

Simplify's Take

What believers are saying

  • Increased demand for liquid biopsy techniques boosts Natera's cfDNA testing solutions.
  • Telehealth expansion aligns with Natera's remote genetic counseling services.
  • Growing personalized medicine trend enhances relevance of Natera's ctDNA tests.

What critics are saying

  • Hindenburg report alleges deceptive sales practices, risking legal challenges and reputational damage.
  • New Prospera Heart features may face slow adoption by healthcare providers.
  • Fetal RhD NIPT demand may decline post-RhIg shortage, impacting revenue.

What makes Natera unique

  • Natera's Signatera test offers personalized ctDNA analysis for cancer patients.
  • Prospera Heart test uses unique Donor Quantity Score for transplant rejection detection.
  • Fetal RhD NIPT test addresses RhIg shortage, offering early fetal RhD status detection.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible medical plans

Investment options

Time off

Workplace perks

INACTIVE